SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 46 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,915 | -88.1% | 4,419 | -78.9% | 0.00% | – |
| Q3 2022 | $33,000 | -25.0% | 20,984 | -4.6% | 0.00% | – |
| Q2 2022 | $44,000 | +238.5% | 21,987 | +293.3% | 0.00% | – |
| Q1 2022 | $13,000 | +225.0% | 5,591 | +1294.3% | 0.00% | – |
| Q2 2021 | $4,000 | -99.7% | 401 | -99.9% | 0.00% | – |
| Q3 2018 | $1,599,000 | +271.9% | 363,300 | +233.9% | 0.00% | – |
| Q1 2017 | $430,000 | +20.1% | 108,789 | +164.5% | 0.00% | – |
| Q4 2015 | $358,000 | +3.8% | 41,130 | 0.0% | 0.00% | – |
| Q3 2015 | $345,000 | -52.4% | 41,130 | 0.0% | 0.00% | – |
| Q2 2015 | $725,000 | +52.6% | 41,130 | 0.0% | 0.00% | – |
| Q1 2015 | $475,000 | -75.2% | 41,130 | -90.3% | 0.00% | – |
| Q3 2014 | $1,916,000 | -55.7% | 423,800 | -33.9% | 0.00% | -100.0% |
| Q2 2014 | $4,327,000 | -48.1% | 641,100 | -1.4% | 0.00% | 0.0% |
| Q1 2014 | $8,333,000 | +58.3% | 650,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $5,265,000 | – | 650,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 2,186,520 | $38,526,000 | 10.61% |
| Cormorant Asset Management, LP | 1,945,334 | $34,277,000 | 4.56% |
| Aisling Capital LLC | 1,703,855 | $30,022,000 | 4.47% |
| Wildcat Capital Management, LLC | 736,012 | $12,968,000 | 4.44% |
| ACUTA CAPITAL PARTNERS, LLC | 212,402 | $3,743,000 | 2.31% |
| Healthcare Value Capital, LLC | 50,000 | $881,000 | 0.92% |
| EAM Investors, LLC | 249,028 | $4,388,000 | 0.51% |
| TFS CAPITAL LLC | 150,812 | $2,657,000 | 0.26% |
| GAGNON SECURITIES LLC | 11,001 | $194,000 | 0.08% |
| Granite Investment Partners, LLC | 43,861 | $772,000 | 0.07% |